title: Comparative study on the antiviral activity of tumor necrosis factor (TNF)-alpha, lymphotoxin/TNF-beta, and IL-1 in WISH cells.
abstract: We find that pretreatment of WISH cells with tumor necrosis factor (TNF)-alpha, IL-1, and lymphotoxin/TNF-beta is capable of inducing an antiviral state in these cells, thereby protecting them from vesicular stomatitis virus cytopathic effect. Furthermore, we find that such a treatment causes a major inhibition of the synthesis of VSV proteins, as analyzed by SDS-PAGE. The 2-5A synthetase activity is also increased by treating the cells with doses of cytokines effective in antiviral protection. In this cell system, inclusion of polyclonal antibodies to IFN-beta during cytokine pretreatment abrogates the antiviral state elicited by the above cytokines, while antibodies to IFN-beta 2/IL-6 fail to abolish the cytokine-induced antiviral effects.
authors.affiliation: Institute of Virology, La Sapienza University, Rome, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Ruggiero
authors.forename: G
authors.initials: G
authors.lastname: Antonelli
authors.forename: M
authors.initials: M
authors.lastname: Gentile
authors.forename: G
authors.initials: G
authors.lastname: Conciatori
authors.forename: F
authors.initials: F
authors.lastname: Dianzani
mesh_terms: D015088:2',5'-Oligoadenylate Synthetase / Q000032:analysis / Q000378:metabolism; D002460:Cell Line; D002478:Cells, Cultured; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology*; D008233:Lymphotoxin-alpha / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*; D014721:Vesicular stomatitis Indiana virus / Q000187:drug effects*; D014762:Viral Interference; D014764:Viral Proteins / Q000378:metabolism*
chemical_list: D007375:Interleukin-1; D008233:Lymphotoxin-alpha; D014409:Tumor Necrosis Factor-alpha; D014764:Viral Proteins; D015088:2',5'-Oligoadenylate Synthetase